Christine Wesström
Directeur Technique/Scientifique/R&D chez SWEDISH ORPHAN BIOVITRUM AB
Fortune : 281 398 $ au 30/04/2024
Provenance du réseau au premier degré de Christine Wesström
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 74 | |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden.
10
| Private Company | Miscellaneous Commercial Services | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Christine Wesström via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BAXTER INTERNATIONAL INC. | Medical Specialties | Chief Tech/Sci/R&D Officer Sales & Marketing | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
INVESTOR AB | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
GENOVIS AB | Medical Specialties | Director/Board Member Chief Executive Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Public Communications Contact Chief Executive Officer Director/Board Member | |
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Chairman Director of Finance/CFO | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member | |
MEDA AB | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Director/Board Member | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal General Counsel Director/Board Member | |
RECIPHARM AB (PUBL) | Biotechnology | Director of Finance/CFO Director/Board Member Public Communications Contact | |
Karolinska Institutet | College/University | Director/Board Member Doctorate Degree Doctorate Degree Doctorate Degree | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OREXO AB | Pharmaceuticals: Major | Chairman Chairman Chief Tech/Sci/R&D Officer | |
Investor AB (Investment Company)
Investor AB (Investment Company) Financial ConglomeratesFinance Investor AB (Investment Company) (Investor-IC) is the investment division of Investor AB (STO: INVE-B; LSE: INU), a Swedish public company established in 1916 as the investment vehicle for the Wallenberg family, which still owns a significant part of the firm. Investor AB is an industrial holding company which manages private equity funds listed on the Swedish stock exchange. Headquartered in Stockholm, Investor-IC is a socially responsible investor which supports the OECD Guidelines for Multinational Enterprises, including anti-corruption and human rights. They are committed to the development of society at large and sponsor youth, education and entrepreneurship activities. | Financial Conglomerates | Chief Investment Officer Chief Investment Officer Portfolio Manager-Equities | |
Syncron Holding AB
Syncron Holding AB Packaged SoftwareTechnology Services Syncron Holding AB provides supply chain management and software solutions. It offers solutions for supply chain planning, business process platform, and global order, supply, and price management. The company's services include professional and inventory planning analyst services, and customer support. Its solutions include global inventory and order management, master data management, business process platform and advanced analytics. Syncron Holding was founded by Hakan Amnas in 1990 and is headquartered in Stockholm, Sweden. | Packaged Software | Director/Board Member Director of Finance/CFO | |
Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Masters Business Admin Director/Board Member Graduate Degree | |
University of Uppsala | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
University of Stockholm | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Investor Relations Contact General Counsel | |
CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
University of Lund | College/University | Graduate Degree Masters Business Admin Director/Board Member Graduate Degree Undergraduate Degree | |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer | |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer Director/Board Member | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Corporate Officer/Principal | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer Director/Board Member Director of Finance/CFO Director/Board Member | |
Hi3G Access AB
Hi3G Access AB Specialty TelecommunicationsCommunications Hi3G Access AB provides mobile communication services. It offers cellular phone services, paging services, wireless Internet access, and wireless video services. The company was founded in December 2000 and is headquartered in Stockholm, Sweden. | Specialty Telecommunications | Director/Board Member Director/Board Member | |
SCANDIC HOTELS GROUP AB | Hotels/Resorts/Cruise lines | Human Resources Officer Human Resources Officer | |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal General Counsel | |
TFS Trial Form Support International AB
TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
GE UK Group
GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous | General Counsel Corporate Officer/Principal | |
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Investor Relations Contact Director/Board Member | |
Patricia Industries AB
Patricia Industries AB Investment ManagersFinance Patricia Industries AB (Patricia Industries) is a private equity subsidiary of Investor AB founded in 1972. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Consultant / Advisor Director of Finance/CFO | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member President | |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President Director/Board Member | |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistiques
Internationale
Suède | 37 |
Etats-Unis | 7 |
Royaume-Uni | 4 |
Danemark | 3 |
France | 2 |
Sectorielle
Health Technology | 30 |
Consumer Services | 10 |
Finance | 5 |
Commercial Services | 5 |
Electronic Technology | 2 |
Opérationnelle
Director/Board Member | 459 |
Corporate Officer/Principal | 157 |
Chairman | 117 |
Independent Dir/Board Member | 114 |
Chief Executive Officer | 87 |
Relations les plus connectées
- Bourse
- Insiders
- Christine Wesström
- Connexions Sociétés